TVARDI THERAPEUTICS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $227.5M | $13.5M |
| FY2022 | — | $158.8M | $63.7M |
| FY2023 | — | $-62.1M | $51.8M |
| FY2024 | — | $-91.1M | $31.6M |
| FY2025 | — | $20.9M | $20.7M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $227.5M | $13.5M |
| FY2022 | — | $158.8M | $63.7M |
| FY2023 | — | $-62.1M | $51.8M |
| FY2024 | — | $-91.1M | $31.6M |
| FY2025 | — | $20.9M | $20.7M |